Cancer Reappears in Patient Following COVID-19 Vaccination: Peer-Reviewed Journal 'Infection' Case Study

Kaposi's sarcoma is a form of cancer originating from the cells that make up the inner lining of blood or lymphatic vessels.

A new publication in the peer-reviewed medical journal Infection reported the reappearance of Kaposi’s sarcoma (KS), a type of cancer that develops from the cells that line lymph or blood vessels, in a 48-year-old male patient who recently received multiple COVID-19 vaccinations.

In 2008, the patient had been diagnosed with HIV infection and KS on his right foot sole and lower leg.

In May 2021, he received the first dose of Moderna’s mRNA-1273 coronavirus vaccine.

In June 2021, he was given a second dose of Moderna’s jab.

“[A]pproximately one week later he noticed two small flat, dark lesions on the sole of his right foot,” the publication reads.

In December 2021, the patient received a Pfizer booster dose (BNT162b2).

“Approximately one week later one of the lesions on his sole progressed to an ulcerative tumor,” the authors explain.

Doctors administered antiretroviral combination therapy, following which “both KS lesions showed spontaneous remission within six months.”

Blood samples also confirmed Human Herpesvirus 8 (HHV-8) DNA was detectable in the patient, despite not being detectable years earlier,

The authors concluded that the patient’s HHV-8 reactivation and the reoccurrence of KS lesions following a three-dose series of COVID shots “suggests HHV-8 reactivation and KS reoccurrence as an adverse event of mRNA vaccination.”